These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy. Jahangiri P; Pournazari K; Torigian DA; Werner TJ; Swisher-McClure S; Simone CB; Alavi A Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):206-216. PubMed ID: 30229527 [TBL] [Abstract][Full Text] [Related]
7. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC). Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718 [TBL] [Abstract][Full Text] [Related]
8. Delayed Yan H; Zhou X; Wang X; Li R; Shi Y; Xia Q; Wan L; Huang G; Liu J Radiology; 2019 Oct; 293(1):144-150. PubMed ID: 31407969 [TBL] [Abstract][Full Text] [Related]
9. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study. Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487 [TBL] [Abstract][Full Text] [Related]
12. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer. Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091 [TBL] [Abstract][Full Text] [Related]
13. PET/CT Imaging of NSCLC with a α Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study. Quartuccio N; Evangelista L; Alongi P; Caobelli F; Altini C; Cistaro A; Lambertini A; Schiorlin I; Popescu CE; Linguanti F; Laudicella R; Scalorbi F; Di Pierro G; Asabella AN; Cuppari L; Margotti S; Lima GM; Scalisi S; Pacella S; Kokomani A; Ciaccio A; Sturiale L; Vento A; Cardile D; Baldari S; Panareo S; Fanti S; Rubini G; Schillaci O; Chiaravalloti A; Nucl Med Commun; 2019 Aug; 40(8):808-814. PubMed ID: 31136534 [TBL] [Abstract][Full Text] [Related]
15. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I; Sivrikoz MC; Entok E; Vardareli E Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390 [TBL] [Abstract][Full Text] [Related]
17. Repeatability of [ Kolinger GD; Vállez García D; Kramer GM; Frings V; Smit EF; de Langen AJ; Dierckx RAJO; Hoekstra OS; Boellaard R EJNMMI Res; 2019 Feb; 9(1):14. PubMed ID: 30734113 [TBL] [Abstract][Full Text] [Related]
18. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI. Schaarschmidt BM; Buchbender C; Nensa F; Grueneisen J; Gomez B; Köhler J; Reis H; Ruhlmann V; Umutlu L; Heusch P PLoS One; 2015; 10(1):e0116277. PubMed ID: 25574968 [TBL] [Abstract][Full Text] [Related]
20. A phase II clinical trial to investigate the effect of pioglitazone on (18)F-FDG uptake in malignant lesions. Han YH; Kwon SY; Kim J; Na CJ; Choi S; Min JJ; Bom HS; Kim YC; Oh IJ; Chae HJ; Lim ST; Sohn MH; Jeong HJ EJNMMI Res; 2015 Dec; 5(1):50. PubMed ID: 26408008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]